Over-expression of deubiquitinating enzyme USP14 in lung adenocarcinoma promotes proliferation through the accumulation of β-catenin

International Journal of Molecular Sciences

Volumn 14, Issue 6, 2013, Pages 10749-10760

  Wu, Ning ^a   Liu, Cong ^b   Bai, Chong ^a   Han, Yi Ping ^a   Cho, William C S ^c   Li, Qiang ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

NSCLC; Prognosis; Proliferation; USP14; catenin

Indexed keywords

BETA CATENIN; CELL ENZYME; DEUBIQUITINATING ENZYME USP14; MESSENGER RNA; UNCLASSIFIED DRUG; UBIQUITIN THIOLESTERASE; USP14 PROTEIN, HUMAN;

ARTICLE; BIOACCUMULATION; CANCER PROGNOSIS; CANCER SURVIVAL; CELL CYCLE ARREST; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; FLUORESCENCE ACTIVATED CELL SORTING; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE; TUMOR GROWTH; UPREGULATION; WESTERN BLOTTING; ADENOCARCINOMA; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; LUNG TUMOR; METABOLISM; NON SMALL CELL LUNG CANCER; PATHOLOGY; SURVIVAL;

ADENOCARCINOMA; BETA CATENIN; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; SURVIVAL ANALYSIS; UBIQUITIN THIOLESTERASE;

EID: 84878208622     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms140610749     Document Type: Article

References (43)

1. Ramalingam, S.S.; Owonikoko, T.K.; Khuri, F.R. Lung cancer: New biological insights and recent therapeutic advances. CA Cancer J. Clin. 2011, 61, 91-112.
2. Katlic, M.R.; Facktor, M.A.; Berry, S.A.; McKinley, K.E.; Bothe, A., Steele, G.D., Proven Care lung cancer: A multi-institutional improvement collaborative. CA Cancer J. Clin. 2011, 61, 382-396.
3. Xinxin Li, Wang, J.; Xu, Z.; Ahmad, A.; Li, E.; Wang, Y.; Qin, S.; Wang, Q. Expression of Sox2 and Oct4 and their clinical significance in human non-small-cell lung cancer. Int. J. Mol. Sci. 2012, 13, 7663-7675.
4. Wen, C.; Dehnel, T. China wrestles with lung cancer. Lancet Oncol. 2011, 12, 15.
5. Wakelee, H.A.; Chang, E.T.; Gomez, S.L.; Keegan, T.H.; Feskanich, D.; Clarke, C.A.; Holmberg, L.; Yong, L.C.; Kolonel, L.N.; Gould, M.K.; West, D.W. Lung cancer incidence in never smokers. J. Clin. Oncol. 2007, 25, 472-478.
6. Fujii, T.; Dracheva, T.; Player, A.; Chacko, S.; Clifford, R.; Strausberg, R.L.; Buetow, K.; Azumi, N.; Travis, W.D.; Jen1, J. A preliminary transcriptome map of non-small cell lung cancer. Cancer Res. 2002, 62, 3340-3346.
7. Sowa, M.E.; Bennett, E.J.; Gygi, S.P.; Harper, J.W. Defining the human deubiquitinating enzyme interaction landscape. Cell 2009, 138, 389-403.
8. Lee, B.H.; Lee, M.J.; Park, S.; Oh, D.-C.; Elsasser, S.; Chen, P.-C.; Gartner, C.; Dimova, N.; Hanna, J.; Gygi, S.P. Enhancement of proteasome activity by a small-molecule inhibitor of USP14. Nature 2010, 467, 179-184.
9. Anderson, C.; Crimmins, S.; Wilson, J.A.; Korbel, G.A.; Ploegh, H.L.; Wilson, S.M. Loss of Usp14 results in reduced levels of ubiquitin in ataxia mice. J. Neurochem. 2005, 95, 724-731.
10. Nag, D.K.; Finley, D. A small-molecule inhibitor of deubiquitinating enzyme USP14 inhibits Dengue virus replication. Virus Res. 2012, 165, 103-106.
11. Peth, A.; Besche, H.C.; Goldberg, A.L. Ubiquitinated proteins activate the proteasome by binding to Usp14/Ubp6, which causes 20S gate opening. Mol. Cell 2009, 36, 794-804.
12. Mines, M.A.; Goodwin, J.S.; Limbird, L.E.; Cui, F.F.; Fan, G.H. Deubiquitination of CXCR4 by USP14 is critical for both CXCL12-induced CXCR4 degradation and chemotaxis but not ERK ativation. J. Biol. Chem. 2009, 284, 5742-5752.
13. Wilson, S.M.; Bhattacharyya, B.; Rachel, R.A.; Coppola, V.; Tessarollo, L.; Householder, D.B.; Fletcher, C.F.; Miller, R.J.; Copeland, N.J.; Jenkins, N.A. Synaptic defects in ataxia mice result from a mutation in Usp14, encoding a ubiquitin-specific protease. Nat. Genet. 2002, 32, 420-425.
14. Borodovsky, A.; Kessler, B.M.; Casagrande, R.; Overkleeft, H.S.; Wilkinson, K.D.; Ploegh, H.L. A novel active site-directed probe specific for deubiquitylating enzymes reveals proteasome association of USP14. EMBO J. 2001, 20, 5187-5196.
15. Ishiwata, S.; Katayama, J.; Shindo, H.; Ozawa, Y.; Itoh, K.; Mizugaki, M. Increased expression of queuosine synthesizing enzyme, tRNA-guanine transglycosylase, and queuosine levels in tRNA of leukemic cells. J. Biochem. 2001, 129, 13-17.
16. Shinji, S.; Naito, Z.; Ishiwata, S.; Ishiwata, T.; Tanaka, N.; Furukawa, K.; Suzuki, H.; Seya, T.; Matsuda, A.; Katsuta, M.; Tajiri, T. Ubiquitin-specific protease 14 expression in colorectal cancer is associated with liver and lymph node metastases. Oncol. Rep. 2006, 15, 539-543.
17. Chuensumran, U.; Saelee, P.; Punyarit, P.; Wongkham, S.; Pairojkul, C.; Chauin, S.; Petmitr, S. Ubiquitin-specific protease 14 expression associated with intrahepatic cholangiocarcinoma cell differentiation. Asian Pac. J. Cancer Prev. 2011, 12, 775-779.
18. Yang, L.; Chen, Y.; Cui, T.; Knösel1, T.; Zhang, Q.; Albring, K.F.; Huber, O.; Petersen, I. Desmoplakin acts as a tumor suppressor by inhibition of the Wnt/beta-catenin signaling pathway in human lung cancer. Carcinogenesis 2012, 33, 1863-1870.
19. Tsao, C.M.; Yan, M.D.; Shih, Y.L.; Yu, P.N.; Kuo, C.C.; Lin, W.C.; Li, H.J.; Lin, Y.W. SOX1 functions as a tumor suppressor through antagonizing the WNT/beta-catenin signaling pathway in hepatocellular carcinoma. Hepatology 2012, 56, 2277-2287.
20. Subbaiah, V.K.; Narayan, N.; Massimi, P.; Banks, L. Regulation of the DLG tumor suppressor by beta-catenin. Int. J. Cancer 2012, 131, 2223-2233.
21. Yoshioka, S.; King, M.L.; Ran, S.; Okuda, H.; MacLean, J.A.; McAsey, M.E.; Sugino, N.; Brard, L.; Watabe, K.; Hayashi, K. WNT7A regulates tumor growth and progression in ovarian cancer through the WNT/beta-catenin pathway. Mol. Cancer Res. 2012, 10, 469-482.
22. Shu, X.S.; Geng, H.; Li, L.; Ying, J.; Ma, C.; Wang, Y.; Poon, F.F.; Wang, X.; Ying, Y.; Yeo, W. The epigenetic modifier PRDM5 functions as a tumor suppressor through modulating WNT/ beta-catenin signaling and is frequently silenced in multiple tumors. PLoS One 2011, 6, e27346.
23. Wang, E.Y.; Yeh, S.H.; Tsai, T.F.; Huang, H.P.; Jeng, Y.M.; Lin, W.H.; Chen, W.C.; Yeh, K.H.; Chen, P.J.; Chen, D.S. Depletion of beta-catenin from mature hepatocytes of mice promotes expansion of hepatic progenitor cells and tumor development. Proc. Natl. Acad. Sci. USA 2011, 108, 18384-18389.
24. Sadot, E.; Simcha, I.; Iwai, K.; Ciechanover, A.; Geiger, B.; Ben-Ze'ev, A. Differential interaction of plakoglobin and beta-catenin with the ubiquitin-proteasome system. Oncogene 2000, 19, 1992-2001.
25. Tran, H.; Polakis, P. Reversible modification of adenomatous polyposis coli (APC) with K63-linked polyubiquitin regulates the assembly and activity of the beta-catenin destruction complex. J. Biol. Chem. 2012, 287, 28552-28563.
26. Jeong, W.J.; Yoon, J.; Park, J.C.; Lee, S.H.; Lee, S.H.; Kaduwal, S.; Kim, H.; Yoon, J.-B.; Choi, K.-Y. Ras stabilization through aberrant activation of Wnt/beta-catenin signaling promotes intestinal tumorigenesis. Sci. Signal. 2012, 5, doi:10.1126/scisignal.2002242.
27. Chen, P.C.; Qin, L.N.; Li, X.M.; Walters, B.J.; Wilson, J.A.; Mei, L.; Wilson, S.M. The proteasome-associated deubiquitinating enzyme Usp14 is essential for the maintenance of synaptic ubiquitin levels and the development of neuromuscular junctions. J. Neurosci. 2009, 29, 10909-10919.
28. Hu, M.; Li, P.; Song, L.; Jeffrey, P.D.; Chernova, T.A.; Wilkinson, K.D.; Cohen, R.E.; Shi, Y. Structure and mechanisms of the proteasome-associated deubiquitinating enzyme USP14. EMBO J. 2005, 24, 3747-3756.
29. Inui, M.; Manfrin, A.; Mamidi, A.; Martello, G.; Morsut, L.; Soligo, S.; Enzo, E.; Moro, S.; Polo, S.; Dupont, S.; et al. USP15 is a deubiquitylating enzyme for receptor-activated SMADs. Nat. Cell Biol. 2011, 13, 1368-1375.
30. Eichhorn, P.J.; Rodon, L.; Gonzalez-Junca, A.; Dirac, A.; Gili, M.; Martínez-Sáez, E.; Aura, C.; Barba, I.; Peg, V.; Prat, A.; et al. USP15 stabilizes TGF-beta receptor I and promotes oncogenesis through the activation of TGF-beta signaling in glioblastoma. Nat. Med. 2012, 18, 429-435.
31. Wu, N.; Gu, H.J.; Li, Q. Effects of antidiabetic drug metformin on the migration and invasion abilities of human pulmonary adenocarcinoma A549 cell line in vitro. J. Thorac. Dis. 2010, 2, 76-80.
32. Hao, J.; Zhang, S.; Zhou, Y.; Hu, X.; Shao, C. MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer. FEBS Lett. 2011, 585, 207-213.
33. Hao, J.; Zhang, S.; Zhou, Y.; Liu, C.; Hu, X.; Shao, C. MicroRNA 421 suppresses DPC4/Smad4 in pancreatic cancer. Biochem. Biophys. Res. Commun. 2011, 406, 552-557.
34. Liu, C.; Li, B.; Cheng, Y.; Lin, J.; Hao, J.; Zhang, S.; Mitchel, R.E.J.; Sun, D.; Ni, J.; Zhao, L.; et al. MiR-21 plays an important role in radiation induced carcinogenesis in BALB/c mice by directly targeting the tumor suppressor gene Big-h3. Int. J. Biol. Sci. 2011, 7, 347-363.
35. Chen, T.; Guo, J.; Yang, M.; Han, C.; Zhang, M.; Chen, W.; Liu, Q.; Wang, J.; Cao, X. Cyclosporin A impairs dendritic cell migration by regulating chemokine receptor expression and inhibiting cyclooxygenase-2 expression. Blood 2004, 103, 413-421.
36. Xu, X.S.; Wang, L.; Abrams, J.; Wang, G. Histone deacetylases (HDACs) in XPC gene silencing and bladder cancer. J. Hematol. Oncol. 2011, 4, 1-11.
37. Lv, T.; Yuan, D.; Miao, X.; Lv, Y.; Zhan, P.; Shen, X.; Song, Y. Over-expression of LSD1 promotes proliferation, migration and invasion in non-small cell lung cancer. PLoS One 2012, 7, e35065.
38. Liu, C.; Gao, F.; Li, B.; Mitchel, R.E.J.; Liu, X.; Lin, J.; Zhao, L.; Cai, J. TLR4 knockout protects mice from radiation-induced thymic lymphoma by downregulation of IL6 and miR-21. Leukemia 2011, 25, 1516-1519.
39. Liu, C.; Zhou, C.; Gao, F.; Cai, S.; Zhang, C.; Zhao, L.; Zhao, F.; Cao, F.; Lin, J.; Yang, Y.; et al. MiR-34a in age and tissue related radio-sensitivity and serum miR-34a as a novel indicator of radiation injury. Int. J. Biol. Sci. 2011, 7, 221-233.
40. Liu, C.; Lin, J.; Zhao, L.; Yang, Y.; Gao, F.; Li, B.; Cui, J.; Cai, J. Gamma-ray irradiation impairs dendritic cell migration to CCL19 by down-regulation of CCR7 and induction of cell apoptosis. Int. J. Biol. Sci. 2011, 7, 168-179.
41. Hofig, I.; Atkinson, M.J.; Mall, S.; Krackhardt, A.M.; Thirion, C.; Anastasov, N. Poloxamer synperonic F108 improves cellular transduction with lentiviral vectors. J. Gene Med. 2012, 14, 549-560.
42. Luche, R.M.; Enssle, J.; Kiem, H.P. Abrogated cryptic activation of lentiviral transfer vectors. Sci. Rep. 2012, 2, doi:10.1038/srep00438.
43. Wu, D.T.; Seita, Y.; Zhang, X.; Lu, C.W.; Roth, M.J. Antibody-directed lentiviral gene transduction for live-cell monitoring and selection of human iPS and hES cells. PLoS One 2012, 7, e34778